Horizon Therapeutics Common
|
11.5 |
$764M |
|
7.0M |
109.14 |
Apellis Pharmaceuticals Common
(APLS)
|
11.1 |
$733M |
|
11M |
65.96 |
United Therapeutics Corp Common
(UTHR)
|
9.7 |
$643M |
|
2.9M |
223.96 |
Sarepta Therapeutics Common
(SRPT)
|
8.1 |
$538M |
|
3.9M |
137.83 |
Argenx Se Sponsored ADR
(ARGX)
|
7.2 |
$480M |
|
1.3M |
372.58 |
Madrigal Pharmaceuticals Common
(MDGL)
|
6.1 |
$404M |
|
1.7M |
242.26 |
Biomarin Pharmaceutical Common
(BMRN)
|
5.8 |
$384M |
|
3.9M |
97.24 |
Seagen Common
|
5.5 |
$365M |
|
1.8M |
202.47 |
Ascendis Pharma Sponsored ADR
(ASND)
|
5.4 |
$357M |
|
3.3M |
107.22 |
Amicus Therapeutics Common
(FOLD)
|
4.6 |
$303M |
|
27M |
11.09 |
Alnylam Pharmaceuticals Common
(ALNY)
|
3.3 |
$221M |
|
1.1M |
200.32 |
Mirati Therapeutics Common
|
3.1 |
$207M |
|
5.6M |
37.18 |
Xenon Pharmaceuticals Common
(XENE)
|
2.6 |
$175M |
|
4.9M |
35.79 |
Krystal Biotech Common
(KRYS)
|
2.1 |
$140M |
|
1.8M |
80.06 |
Kymera Therapeutics Common
(KYMR)
|
1.7 |
$114M |
|
3.9M |
29.63 |
Dice Therapeutics Common
|
1.7 |
$113M |
|
4.0M |
28.65 |
Cymabay Therapeutics Common
|
1.4 |
$90M |
|
10M |
8.72 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.3 |
$87M |
|
10M |
8.34 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.8 |
$56M |
|
2.7M |
21.12 |
Nuvalent Common
(NUVL)
|
0.7 |
$49M |
|
1.9M |
26.09 |
Iovance Biotherapeutics Common
(IOVA)
|
0.6 |
$43M |
|
7.0M |
6.11 |
Avidity Biosciences Common
(RNA)
|
0.6 |
$39M |
|
2.5M |
15.35 |
Kura Oncology Common
(KURA)
|
0.6 |
$38M |
|
3.1M |
12.23 |
Mannkind Corp Common
(MNKD)
|
0.6 |
$37M |
|
9.1M |
4.10 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.5 |
$34M |
|
4.3M |
7.79 |
Mersana Therapeutics Common
(MRSN)
|
0.5 |
$31M |
|
7.6M |
4.11 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.5 |
$30M |
|
750k |
40.10 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.3 |
$22M |
|
3.2M |
6.90 |
Aadi Biosciences Common
(AADI)
|
0.3 |
$21M |
|
2.8M |
7.24 |
Design Therapeutics Common
(DSGN)
|
0.3 |
$20M |
|
3.5M |
5.77 |
Verrica Pharmaceuticals Common
(VRCA)
|
0.3 |
$17M |
|
2.7M |
6.50 |
Iveric Bio Common Call Option
|
0.2 |
$16M |
|
7.7M |
2.10 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.2 |
$15M |
|
3.1M |
4.77 |
Amylyx Pharmaceuticals Common
(AMLX)
|
0.2 |
$14M |
|
473k |
29.34 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$10M |
|
1.2M |
8.32 |
Seres Therapeutics Common
(MCRB)
|
0.1 |
$7.3M |
|
1.3M |
5.67 |
Tango Therapeutics Common
(TNGX)
|
0.1 |
$6.5M |
|
1.6M |
3.95 |
Io Biotech Common
(IOBT)
|
0.1 |
$3.8M |
|
2.1M |
1.87 |
Spdr Series Trust - S&p Biotech Etf Call Option
(XBI)
|
0.0 |
$180k |
|
1.5M |
0.12 |